Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellowship, Infectious Diseases, Duke University School of Medicine 2016 - 2017
  • Infectious Diseases, Duke University School of Medicine 2014 - 2015
  • Internal Medicine, Duke University School of Medicine 2011 - 2014
  • M.D., Duke University School of Medicine 2011
  • M.P.H., University of North Carolina - Chapel Hill 2010
• 

  Duke Appointment History

  • Medical Instructor in the Department of Medicine, Medicine, Infectious Diseases, Medicine 2017 - 2018
  • Medical Instructor in the Department of Medicine, Medicine, General Internal Medicine, Medicine 2015 - 2017
• Research
• 

  Selected Grants

  • IPA Sara Hoffman awarded by Durham Veterans Affairs Medical Center 2019
• 

  External Relationships

  • GLG Consultants
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Hostler, Christopher J., J Bradford Bertumen, Lawrence P. Park, Susan B. Wilkins, and Christopher W. Woods. “Differences in time-to-testing and time-to-isolation between community-onset and hospital-onset Clostridioides difficile cases at a tertiary care VA medical center.” Am J Infect Control 48, no. 10 (October 2020): 1148–51. https://doi.org/10.1016/j.ajic.2019.12.008.
       Full Text  Link to Item
    • Shoff, Christopher J., Mary L. Townsend, L Gayani Tillekeratne, Ryan D. Schulteis, Michael E. Yarrington, Nicholas A. Turner, Christopher W. Woods, and Christopher J. Hostler. “Improved empiric antibiotic prescribing for acute cystitis with use of local urinary antibiogram and clinical decision support system.” Infect Control Hosp Epidemiol, August 19, 2020, 1–2. https://doi.org/10.1017/ice.2020.357.
       Full Text  Link to Item
    • McRae-Siebenbrodt, Christy, Hans L. Tillmann, and Christopher J. Hostler. “How to Obtain a Nasopharyngeal Swab Specimen.” N Engl J Med 383, no. 3 (July 16, 2020): e14. https://doi.org/10.1056/NEJMc2015949.
       Full Text  Link to Item
    • Warren, David K., Katelin B. Nickel, Jennifer H. Han, Pam Tolomeo, Christopher J. Hostler, Katherine Foy, Ian R. Banks, Victoria J. Fraser, Margaret A. Olsen, and Margaret A. CDC Prevention Epicenter Program. “Postdischarge antibiotic use for prophylaxis following spinal fusion.” Infect Control Hosp Epidemiol, May 5, 2020, 1–10. https://doi.org/10.1017/ice.2020.117.
       Full Text  Link to Item
    • Bari, S., A. Chan, S. R. Jain, and C. J. Hostler. “Outcomes of programmed cell death protein 1 (PD-1) and programmed death-ligand 1(PD-L1) inhibitor therapy in HIV patients with advanced cancer.” Journal of Oncology 2019 (January 1, 2019). https://doi.org/10.1155/2019/2989048.
       Full Text
    • Bari, S., J. Muzaffar, A. Chan, S. R. Jain, A. M. Haider, M. Adams Curry, and C. J. Hostler. “Corrigendum: Outcomes of programmed cell death protein 1 (pd-1) and programmed death-ligand 1 (pd-l1) inhibitor therapy in HIV patients with advanced cancer (Journal of Oncology (2019) 2019 (2989048) DOI: 10.1155/2019/2989048).” Journal of Oncology 2019 (January 1, 2019). https://doi.org/10.1155/2019/7921582.
       Full Text
    • Hostler, Christopher J., Rebekah W. Moehring, Elizabeth S Dodds Ashley, Melissa Johnson, Angelina Davis, Sarah S. Lewis, Daniel J. Sexton, Deverick J. Anderson, and Deverick J. CDC Prevention Epicenters Program. “Feasibility and Value of Developing a Regional Antibiogram for Community Hospitals.” Infect Control Hosp Epidemiol 39, no. 6 (June 2018): 718–22. https://doi.org/10.1017/ice.2018.71.
       Full Text  Link to Item
    • Hostler, Christopher J., and Luke F. Chen. “Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis.” Expert Opin Pharmacother 14, no. 11 (August 2013): 1529–36. https://doi.org/10.1517/14656566.2013.802307.
       Full Text  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.